Description
From Kalorama Information and Science and Medicine Group (publishers of Instrument Business Outlook) comes a new publication focusing on the business of clinical testing.
In Vitro Diagnostics Business Outlook offers the following:
- Market Sizing and Forecasting of IVD Market Segments in Every Issue
- Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
- Industry Watch – Developments with COVID-19 and Other Testing
- M&A, Distribution, Partnerships Tracked and Charted
- New Product Introductions and Company Announcements
- Company Profiling and Quarterly Results Summaries
- Regional Market Coverage
“Kalorama Market Research reports are great, but we need updated market information in between report updates!”
This is what Kalorama has heard from customers, and we’ve responded with an updated newsletter covering the in vitro diagnostics market.
Who Is Dealing with Whom?
Tracking of M&A and Partnerships In Every Issue
No in vitro diagnostics company possesses all the technology needed to succeed. Major IVD companies pursue opportunities for acquisition of other companies to complete technology offerings as needed. Partnership agreements are inked and competitors become cooperators and competitors again, across many product segments.
How can you keep track of it? Each issue of In Vitro Diagnostics Business Outlook will keep track of mergers, investments, licensing, technology transfers and partnerships in the industry. Each issue of In Vitro Diagnostics Business Outlook contains an updated IVD Recent Deals Table with information on these important events.
Future issues will also analyze the number of deals and increases or decreases in activity as a measure of business. You’ll never miss an important happening with In Vitro Diagnostics Business Outlook.
Finding markets with higher growth than the average is critical
International Region Watch
IVD companies compete internationally. Finding markets with higher growth than the average is critical. There are specific developments in various countries and regions. In Vitro Diagnostics Business Outlook will offer regional market coverage on a regular basis, focusing on a few countries or regions in each issue.
With issues 2x a month, this newsletter dedicated to In Vitro Diagnostics is the best way to keep up in this rapidly-developing and well financed field.
Convenient and Cost-Effective Seat-Based Pricing
Pricing depends on the number of users. Subscriptions can be as low as $2,200 annually for a limited one-person (single user) subscription. If more than one person will be reading, you can unlock access to other members of your organization. It’s easy to do: team subscription prices are as little as $4,995 annually for up to five readers.
| License | 1 Year (24 Issues) |
2 Years (save 10%) |
3 Years (save 15%) |
|---|---|---|---|
| Team (5 Users) |
$4,995 | $8,990 | $12,735 |
| Group (15 Users) |
$6,995 | $12,590 | $17,885 |
| Department (50 Users) |
$11,995 | $21,590 | $30,585 |
| Corporate (250 Users) |
$19,995 | $35,990 | $50,985 |
| Enterprise (Unlimited Users) |
$30,000 | Inquire | Inquire |
